Y Kuboki
Overview
Explore the profile of Y Kuboki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1845
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenz H, Argiles G, de Jonge M, Yaeger R, Doi T, El-Khoueiry A, et al.
ESMO Open
. 2024 Dec;
9(11):103729.
PMID: 39617530
Background: Aberrant Wnt pathway signaling has been implicated in the development of many cancers. Targeting of low-density lipoprotein receptor-related protein 5/6 (LRP5/6) co-receptors inhibits Wnt signaling and may be a...
2.
Kubota Y, Kawazoe A, Mishima S, Nakamura Y, Kotani D, Kuboki Y, et al.
ESMO Open
. 2024 Jan;
9(1):102232.
PMID: 38194883
No abstract available.
3.
Kubota Y, Kawazoe A, Mishima S, Nakamura Y, Kotani D, Kuboki Y, et al.
ESMO Open
. 2023 Jan;
8(1):100762.
PMID: 36610262
Background: We conducted comprehensive clinical and molecular characterization of claudin 18.2 expression (CLDN18.2) in advanced gastric or gastroesophageal junction cancer (GC/GEJC). Patients And Methods: Patients with advanced GC/GEJC who received...
4.
Oki E, Watanabe J, Sato T, Kagawa Y, Kuboki Y, Ikeda M, et al.
ESMO Open
. 2021 May;
6(3):100146.
PMID: 33984677
Background: Recent advances in adjuvant chemotherapy for early colon cancer have widened physicians' recommendations on the regimen and duration (3 or 6 months) of the treatment. We conducted this prospective...
5.
Kuboki Y, Yamashita S, Niwa T, Ushijima T, Nagatsuma A, Kuwata T, et al.
Ann Oncol
. 2015 Oct;
27(1):127-33.
PMID: 26489445
Background: In advanced gastric cancer (AGC), most clinical trials are designed on the basis of protein expression or gene amplification of specific genes. Recently, next-generation sequencing (NGS) allowed us to...
6.
Matsuura T, Akizuki T, Hoshi S, Ikawa T, Kinoshita A, Sunaga M, et al.
J Periodontal Res
. 2014 Jul;
50(3):347-55.
PMID: 25040655
Background And Objective: Tissue regeneration is affected by the porosity, chemical properties and geometric structure of graft materials. Regeneration of severe periodontal defects, such as one-wall intrabony defects, is difficult...
7.
Fukui N, Sato T, Kuboki Y, Aoki H
Biomed Mater Eng
. 2008 Jan;
18(1):25-33.
PMID: 18198404
The purpose of this study was to develop a new biodegradable bone substitute materials consisting of synthesized nano-size hydroxyapatite (nano-HAp) and Type I biodegradable honeycomb collagen sponge (HCS) composites. Bone...
8.
Jansen J, Vehof J, Ruhe P, Kroeze-Deutman H, Kuboki Y, Takita H, et al.
J Control Release
. 2004 Dec;
101(1-3):127-36.
PMID: 15588899
The objective of the study presented here was to investigate the bone inductive properties as well as release kinetics of rhTGF-beta1- and rhBMP-2-loaded Ti-fiber mesh and CaP cement scaffolds. Therefore,...
9.
Takita H, Vehof J, Jansen J, Yamamoto M, Tabata Y, Tamura M, et al.
J Biomed Mater Res A
. 2004 Sep;
71(1):181-9.
PMID: 15368268
To evaluate the osteoinductive effects of recombinant human bone morphogenetic protein (rhBMP)-2 during the early stages of rat ectopic bone formation, we prepared two distinct carriers. Two carriers, insoluble bone...
10.
Kuboki Y, Kikuchi M, Takita H, Yoshimoto R, Nakayama Y, Matsuda T, et al.
Connect Tissue Res
. 2003 Sep;
44 Suppl 1:318-25.
PMID: 12952216
Previously we found that laser perforation of a collagen membrane (35 microm thickness, Koken Co., Tokyo) produced an effective bone morphogenetic protein (BMP) carrier, if the created pore sizes were...